This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NATICK, Mass., Jan. 2, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 32
nd Annual J.P. Morgan Healthcare Conference on
Tuesday, January 14, 2014 in
Mike Mahoney, president and chief executive officer, will make a presentation about the company beginning at approximately
9:00 a.m. PT. Following the presentation,
Dan Brennan, executive vice president and chief financial officer, and
Keith Dawkins, M.D., executive vice president and global chief medical officer, will join Mr. Mahoney in a question and answer session.
A live webcast of the presentation and question and answer session will be available via the Boston Scientific website. Webcast registration is available on the Investor Relations section of the website at
www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
The webcast is being hosted by J.P. Morgan. A replay of the webcast will be archived and accessible at
www.bostonscientific.com/investors approximately one hour following the completion of the question and answer session.
About Boston ScientificBoston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit
www.bostonscientific.com and connect on
CONTACTSMedia: Denise Kaigler 508-650-8330 (office) Corporate Affairs & Communications Boston Scientific Corporation firstname.lastname@example.orgInvestors:Susie Lisa, CFA 508-652-5345 (office)Investor RelationsBoston Scientific Corporationinvestor_relations@bsci.com